Effect of small molecule inhibitors of JAK2 kinase on modulating signaling cascades downstream of cytokine receptors

被引：0
|
作者：
Olsen, Colin E. [1 ]
Gourley, Eric S. [1 ]
Liu, Xiao-Hui [1 ]
Walker, Jeff [1 ]
Grand, Cory L. [1 ]
Warner, Steven L. [1 ]
Vankayalapati, Hariprasad [1 ]
Bearss, David J. [1 ]
机构：
[1] SuperGen Inc, Dublin, CA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3592S / 3592S
页数：1
相关论文
共 50 条
  • [21] Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling
    Feener, EP
    Rosario, F
    Dunn, SL
    Stancheva, Z
    Myers, MG
    MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (11) : 4968 - 4978
  • [22] Identification and Characterization of JAK2 Pseudokinase Domain Small Molecule Binders
    Puleo, David E.
    Kucera, Kaury
    Hammaren, Henrik M.
    Ungureanu, Daniela
    Newton, Ana S.
    Silvennoinen, Olli
    Jorgensen, William L.
    Schlessinger, Joseph
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (06): : 618 - 621
  • [23] Differential effect of inhibitory strategies of the V617 mutant of JAK2 on cytokine receptor signaling
    Leroy, Emilie
    Balligand, Thomas
    Pecquet, Christian
    Mouton, Celine
    Colau, Didier
    Shiau, Andrew K.
    Dusa, Alexandra
    Constantinescu, Stefan N.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (01) : 224 - 235
  • [24] Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2
    Funakoshi-Tago, Megumi
    Pelletier, Stephane
    Matsuda, Tadashi
    Parganas, Evan
    Ihle, James N.
    EMBO JOURNAL, 2006, 25 (20): : 4763 - 4772
  • [25] Germline JAK2 Mutations In The Kinase Domain Are Responsible For Hereditary Thrombocytosis and Are Resistant To JAK2 and HSP90 Inhibitors
    Marty, Caroline
    Saint-martin, Cecile
    Pecquet, Christian
    Grosjean, Sarah
    Saliba, Joseph
    Mouton, Celine
    Emilie, Leroy
    Harutyunyan, Ashot S.
    Abgrall, Jean-Francois
    Favier, Remy
    Solary, Eric
    Kralovics, Robert
    Constantinescu, Stefan N.
    Najman, Albert
    Vainchenker, William
    Plo, Isabelle
    Bellanne-Chantelot, Christine
    BLOOD, 2013, 122 (21)
  • [26] JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease
    Howell, Michael D.
    Fitzsimons, Carolyn
    Smith, Paul A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (04) : 367 - 375
  • [27] Efficacy of LY2784544, a Small Molecule Inhibitor Selective for Mutant JAK2 Kinase, In JAK2 V617F-Induced Hematologic Malignancy Models.
    Ma, Liandong
    Zhao, Baohui
    Walgren, Richard
    Clayton, Joshua A.
    Blosser, Wayne D.
    Burkholder, Timothy P.
    Smith, Michele C.
    BLOOD, 2010, 116 (21) : 1663 - 1664
  • [28] TYROSINE-PROTEIN KINASE JAK2 INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
    Majumder, A.
    Sayeski, P. P.
    DRUGS OF THE FUTURE, 2010, 35 (08) : 651 - 660
  • [29] Identification of tubulin as a substrate of Jak2 tyrosine kinase and its role in Jak2-dependent signaling
    Ma, Xianyue
    Sayeski, Peter P.
    BIOCHEMISTRY, 2007, 46 (24) : 7153 - 7162
  • [30] An Unusual Insertion in Jak2 Is Crucial for Kinase Activity and Differentially Affects Cytokine Responses
    Haan, Claude
    Kroy, Daniela C.
    Wueller, Stefan
    Sommer, Ulrike
    Noecker, Tanja
    Rolvering, Catherine
    Behrmann, Iris
    Heinrich, Peter C.
    Haan, Serge
    JOURNAL OF IMMUNOLOGY, 2009, 182 (05): : 2969 - 2977
12345